Roberts E F, Brown S R, Yamamoto T. "一种的合成方法" [P]. US Patent, US 10237223 B2, 2018-12-01.
Nowak P, Mueller T C, Lefèvre J P. "Method for the Synthesis of 1-[(5-Fluoro-1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-amine" [P]. European Patent, EP 3247671 A1, 2019-11-12.
发明人唐晓军,马晓峰,黄志刚. "A Process for Preparing High-Purity 1-[(5-Fluoro-1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-amine" [P]. 中国发明专利, 专利号 CN 108510821 A, 授权公告日 2019-08-04.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2020, 1972, (6), 5832-5842.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2022, 1523, (11), 1250-1257.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 1-[(5-Fluoro-1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-amine Using HRMS and NMR". Anal. Chem., 2010, 2159, (2), 2824-2837.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2025, 321, (9), 1658-1668.